Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven R Goldstein

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Menopause (New York, N.Y.)|December 12, 2013
Still another selective estrogen receptor modulator to enhance women's health: this time in combination with conjugated equine estrogensSteven R Goldstein
Seminars in Reproductive Medicine|May 28, 2008
Ultrasound scanning in reproductive medicine and infertility. PrefaceSteven R Goldstein
Menopause (New York, N.Y.)|June 24, 2015
Not all SERMs are created equal: chapter 2Steven R Goldstein
Menopause (New York, N.Y.)|January 26, 2005
The case for less-than-monthly progestogen in women on HT: is transvaginal ultrasound the key?Steven R Goldstein
American Journal of Obstetrics and Gynecology|September 19, 2002
Adverse events that are associated with the selective estrogen receptor modulator levormeloxifene in an aborted phase III osteoporosis treatment studySteven R Goldstein, Nayan Nanavati
Obstetrics and Gynecology Clinics of North America|November 4, 2019
Abnormal Uterine BleedingAshraf Khafaga, Steven R Goldstein
Clinical Obstetrics and Gynecology|December 23, 2016
Transvaginal Ultrasound for the Diagnosis of Abnormal Uterine BleedingKaren C Wheeler, Steven R Goldstein
Menopause (New York, N.Y.)|January 29, 2010
Endometrial safety: a key hurdle for selective estrogen receptor modulators in developmentJoAnn V Pinkerton, Steven R Goldstein
Clinical Obstetrics and Gynecology|July 26, 2012
Office diagnosis and management of abnormal uterine bleedingMing C Tsai, Steven R Goldstein
Menopause (New York, N.Y.)|September 2, 2015
Does purified Swedish pollen extract, a nonhormonal treatment for vasomotor symptoms, inhibit the CYP2D6 enzyme system?Steven R Goldstein, Marc Espié, René Druckmann
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Menopause (New York, N.Y.)|December 12, 2013
Still another selective estrogen receptor modulator to enhance women's health: this time in combination with conjugated equine estrogensSteven R Goldstein
Seminars in Reproductive Medicine|May 28, 2008
Ultrasound scanning in reproductive medicine and infertility. PrefaceSteven R Goldstein
Menopause (New York, N.Y.)|June 24, 2015
Not all SERMs are created equal: chapter 2Steven R Goldstein
Menopause (New York, N.Y.)|January 26, 2005
The case for less-than-monthly progestogen in women on HT: is transvaginal ultrasound the key?Steven R Goldstein
American Journal of Obstetrics and Gynecology|September 19, 2002
Adverse events that are associated with the selective estrogen receptor modulator levormeloxifene in an aborted phase III osteoporosis treatment studySteven R Goldstein, Nayan Nanavati
Obstetrics and Gynecology Clinics of North America|November 4, 2019
Abnormal Uterine BleedingAshraf Khafaga, Steven R Goldstein
Clinical Obstetrics and Gynecology|December 23, 2016
Transvaginal Ultrasound for the Diagnosis of Abnormal Uterine BleedingKaren C Wheeler, Steven R Goldstein
Menopause (New York, N.Y.)|January 29, 2010
Endometrial safety: a key hurdle for selective estrogen receptor modulators in developmentJoAnn V Pinkerton, Steven R Goldstein
Clinical Obstetrics and Gynecology|July 26, 2012
Office diagnosis and management of abnormal uterine bleedingMing C Tsai, Steven R Goldstein
Menopause (New York, N.Y.)|September 2, 2015
Does purified Swedish pollen extract, a nonhormonal treatment for vasomotor symptoms, inhibit the CYP2D6 enzyme system?Steven R Goldstein, Marc Espié, René Druckmann
Pageof 9